Table 1.
Clinicopathologic Features of Primary DLBCL Patients with Later Progression of rrDLBCL
| Clinicopathologic Features | DLBCL (n=46) | rrDLBCL (n=18) | p |
|---|---|---|---|
| Age | 0.417 | ||
| <60 | 26 | 8 | |
| ≥60 | 20 | 10 | |
| Gender | 1 | ||
| Male | 23 | 9 | |
| Female | 23 | 9 | |
| COO classification | 0.24 | ||
| GCB | 10 | 1 | |
| Non-GCB | 36 | 17 | |
| Ann Arbor Staging | 0.044 | ||
| I–II | 19 | 2 | |
| III–IV | 27 | 16 | |
| LDH level (mean±SD) | 378.46±480.99 | 334.72±128.67 | 0.706 |
| IPI | 0.021 | ||
| 0–1 | 21 | 2 | |
| 2–3 | 19 | 10 | |
| 4–5 | 6 | 6 | |
| ALB (mean±SD) | 41.22±5.43 | 39.73±5.35 | 0.327 |
| β-macroglobulin (mean±SD) | 2.98±2.13 | 3.35±1.24 | 0.486 |
| HGB (mean±SD) | 123.02±16.27 | 117.22±19.07 | 0.227 |
| ESR (mean±SD) | 22.76+19.56 | 26.06+17.29 | 0.534 |
| Ca+ (mean±SD) | 2.33±0.17 | 2.27+0.24 | 0.199 |
| DPL | 0.268 | ||
| Yes | 19 | 4 | |
| No | 23 | 12 | |
Abbreviations: IPI, international prognostic index; LDH, lactate dehydrogenase; ALB, albumin; HGB, hemoglobin; ESR, erythrocyte sedimentation rate; DPL, double-protein-expression lymphomas; SD, standard deviation.